RHB-102 improves stool consistency in patients with IBS-D

In men and women with diarrhea-predominant irritable bowel syndrome, RHB-102 was an effective and safe treatment, according to the American Journal of Gastroenterology.“[RHB-102], a once daily bimodal release formulation of ondansetron, significantly improved stool consistency in patients with IBS-D,” Terry F. Plasse, MD, from RedHill Biopharma in Tel Aviv, Israel, and colleagues wrote. “Abdominal pain and composite response were also improved, although the differences were not statistically significant in this relatively small study. Treatment appeared to work at least asRead More

Share on facebook
Share on twitter
Share on linkedin